Truist Securities Initiates Coverage On Cargo Therapeutics with Buy Rating, Announces Price Target of $34
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Asthika Goonewardene has initiated coverage on Cargo Therapeutics (NASDAQ:CRGX) with a Buy rating and set a price target of $34.

December 05, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has initiated coverage on Cargo Therapeutics with a Buy rating and a price target of $34, which could positively influence the stock's performance.
Analyst ratings, especially from reputable firms like Truist Securities, can significantly impact a stock's short-term performance. A Buy rating combined with a price target that suggests substantial upside from the current trading price is likely to be viewed positively by investors, potentially driving up the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100